Inventor

MARASCO WAYNE A

US50 patents

⚠️ This page may combine multiple inventors who share the name “MARASCO WAYNE A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MARASCO WAYNE A

DANA FARBER CANCER INST INC

Method of intracellular binding of target molecules

Method of intracellular binding of target molecules

Intracellular targeting of endogenous proteins

Method of intracellular binding target molecules

Method of intracellular binding of target molecules

Expression vectors and methods of use

Reactive neutralizing human anti-GP120 recombinant antibody, DNA coding the same and use thereof

Chimeric T cell receptor comprising carbonic anhydrase IX (G250) antibody

Lentiviral vector system for high quantity screening

Humanized antibody and uses thereof

Human monoclonal anti-PD-L1 antibodies and methods of use

Pseudotyped lentiviral vectors and uses thereof

Chimeric antigen receptors specific for carbonic acid anhydrase IX

Flavivirus neutralizing antibodies and methods of use thereof

Flavivirus neutralizing antibodies and methods of use thereof

Nucleic acid delivery system, methods of synthesis and use thereof

Method of treating renal cancer using carbonic anhydrase IX (G250) antibodies

Humanized CC chemokine receptor 4 (CCR4) antibodies and methods of use thereof

Carbonic anhydrase IX (G250) antibodies and methods of use thereof

Antibodies against influenza virus and methods of use thereof

Middle east respiratory syndrome coronavirus neutralizing antibodies and methods of use thereof

Chimeric antigen receptors and methods of use thereof

Humanized influenza monoclonal antibodies and methods of use thereof

Method of treating a tumor expressing carbonic anhydrase IX (G250) by administering a G250-specific chimeric antigen receptor

Methods for depleting or inhibiting the migration of regulatory T-cells in early or late stages of cancer

Humanized influenza monoclonal antibodies and methods of use thereof

Flavivirus neutralizing antibodies and methods of use thereof

Human monoclonal anti-PD-L1 antibodies and methods of use

Pharmaceutical compositions comprising humanized anti-CCR4 IgG4 antibody

Humanized CC chemokine receptor 4 (CCR4) antibodies and methods of use thereof

Humanized CC chemokine receptor 4 (CCR4) antibodies and methods of use thereof

Affinity matured anti-CCR4 humanized monoclonal antibodies and methods of use

Immunogenetic restriction on elicitation of antibodies

Humanized monoclonal antibodies and methods of use

Pseudotyped lentiviral vectors and uses thereof

Middle east respiratory syndrome coronavirus neutralizing antibodies and methods of use thereof

Glucocorticoid-induced tumor necrosis factor receptor (GITR) antibodies and methods of use thereof

Antibody to latent membrane proteins and uses thereof

Engineered cells, T cell immune modulating antibodies and methods for using the same

Composition and methods of treating B cell disorders

Glucocorticoid-induced tumor necrosis factor receptor (GITR) antibodies and methods of use thereof

Affinity matured anti-CCR4 humanized monoclonal antibodies and methods of use

Chimeric antigen receptor factories and methods of use thereof

Conserved hemagglutinin epitope, antibodies to the epitope, and methods of use

Middle east respiratory syndrome coronavirus neutralizing antibodies and methods of use thereof

Antibodies against MUC1

MARASCO WAYNE A

Carbonic anhydrase IX (G250) anitbodies

Antibodies against CXCR4 and methods of use thereof

Humanized monoclonal antibodies and methods of use

Lentiviral vectors and uses thereof